PATENT CLAIM ANALYSIS

Application Number: 15876127
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "450000"]

Abstract:
This invention encompasses compounds and compositions useful in methods for medical therapy, in general, for inhibiting expression of a TTR gene in a subject. The compounds have a first strand and a second strand, the monomers comprising UNA monomers and nucleic acid monomers, and the compounds are targeted to a sequence of a TTR gene.

Claim (Index 2):
The compound of  claim 1 , wherein the compound contains one to seven UNA monomers.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 1.64865
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14667678', '15859571', '14807223', '15272107', '15563579']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8431461703856951
- 35 USC 102 Novelty (BERT): 0.6501451294326079
- Combined Prediction Score: 0.8238460662903864
- Mean Citation Score: 602.0331100000002
- Max Citation Score: 764.4272
- Similarity Product: 577.5696437763214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test